reference/8154025

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8154025

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	268
issn	0340-7004 1432-0851
issueIdentifier	2
pageRange	257-268
publicationName	Cancer immunology, immunotherapy : CII
startingPage	257
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ab2d694d4e5ea71bedfdcc1d06647719 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_65ab36d89c80a92c1fcccb7407a2c10a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e578598df8e4fee64fa7b27b288b3837 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cee0550773cd31a668a995b4b1a75f22
bibliographicCitation	Yuan W, Deng D, Jiang H, Tu C, Shang X, He H, Niu R, Dong J. Hyperresponsiveness to interferon gamma exposure as a response mechanism to anti-PD-1 therapy in microsatellite instability colorectal cancer. Cancer Immunol Immunother. 2019 Feb;68(2):257–68. doi: 10.1007/s00262-018-2270-5. PMID: 30406373.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92ed92a7216066e4565b9e43009b5307 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4cfe20c6fac1d39b9314d2474406838 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_446041e2d2b1d64c1b1d1eb8d3148297 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c8f2f1f53ebc858dec0eecb08685b2e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6396-1218 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a19e52997c23d24bee75a939f610fe9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d65593a028819bcbf22905b3c8bd45c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_971130c3ab6f6b050b1ff030e6224808
date	2018-11-07^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/30406373 https://doi.org/10.1007/s00262-018-2270-5
isPartOf	https://portal.issn.org/resource/ISSN/0340-7004 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2781 https://portal.issn.org/resource/ISSN/1432-0851
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Hyperresponsiveness to interferon gamma exposure as a response mechanism to anti-PD-1 therapy in microsatellite instability colorectal cancer
discusses	http://id.nlm.nih.gov/mesh/M0470257 http://id.nlm.nih.gov/mesh/M0011490 http://id.nlm.nih.gov/mesh/M0555734 http://id.nlm.nih.gov/mesh/M0001357
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015972Q000187 http://id.nlm.nih.gov/mesh/D053842 http://id.nlm.nih.gov/mesh/D007371Q000494 http://id.nlm.nih.gov/mesh/D000911Q000494 http://id.nlm.nih.gov/mesh/D015179Q000188 http://id.nlm.nih.gov/mesh/D060890Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D015179Q000276 http://id.nlm.nih.gov/mesh/D015179Q000235 http://id.nlm.nih.gov/mesh/D059016Q000276 http://id.nlm.nih.gov/mesh/D060890Q000276 http://id.nlm.nih.gov/mesh/D059016Q000235 http://id.nlm.nih.gov/mesh/D060890Q000378 http://id.nlm.nih.gov/mesh/D059016Q000187 http://id.nlm.nih.gov/mesh/D045325 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D017209Q000276 http://id.nlm.nih.gov/mesh/D017209Q000235 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D015398Q000276 http://id.nlm.nih.gov/mesh/D015398Q000187 http://id.nlm.nih.gov/mesh/D015398Q000235 http://id.nlm.nih.gov/mesh/D045744
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11010 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_beda6fe677b7a43d27c994ffcbd5e2d6 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6d2eac63192f2d6e4b9b95cd225e2ba7

Showing number of triples: 1 to 67 of 67.